Literature DB >> 23791525

Cryptopatches are essential for the development of human GALT.

Tomonori Nochi1, Paul W Denton, Angela Wahl, J Victor Garcia.   

Abstract

Abnormal gut-associated lymphoid tissue (GALT) in humans is associated with infectious and autoimmune diseases, which cause dysfunction of the gastrointestinal (GI) tract immune system. To aid in investigating GALT pathologies in vivo, we bioengineered a human-mouse chimeric model characterized by the development of human GALT structures originating in mouse cryptopatches. This observation expands our mechanistic understanding of the role of cryptopatches in human GALT genesis and emphasizes the evolutionary conservation of this developmental process. Immunoglobulin class switching to IgA occurs in these GALT structures, leading to numerous human IgA-producing plasma cells throughout the intestinal lamina propria. CD4+ T cell depletion within GALT structures results from HIV infection, as it does in humans. This human-mouse chimeric model represents the most comprehensive experimental platform currently available for the study and for the preclinical testing of therapeutics designed to repair disease-damaged GALT.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23791525      PMCID: PMC3725137          DOI: 10.1016/j.celrep.2013.05.037

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  40 in total

Review 1.  New insights into the development of lymphoid tissues.

Authors:  Serge A van de Pavert; Reina E Mebius
Journal:  Nat Rev Immunol       Date:  2010-08-13       Impact factor: 53.106

Review 2.  Inducible lymphoid tissues in the adult gut: recapitulation of a fetal developmental pathway?

Authors:  Gérard Eberl
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

3.  Identification of multiple isolated lymphoid follicles on the antimesenteric wall of the mouse small intestine.

Authors:  Hiromasa Hamada; Takachika Hiroi; Yasuhiro Nishiyama; Hidemi Takahashi; Yohei Masunaga; Satoshi Hachimura; Shuichi Kaminogawa; Hiromi Takahashi-Iwanaga; Toshihiko Iwanaga; Hiroshi Kiyono; Hiroshi Yamamoto; Hiromichi Ishikawa
Journal:  J Immunol       Date:  2002-01-01       Impact factor: 5.422

Review 4.  Humanized mice for immune system investigation: progress, promise and challenges.

Authors:  Leonard D Shultz; Michael A Brehm; J Victor Garcia-Martinez; Dale L Greiner
Journal:  Nat Rev Immunol       Date:  2012-10-12       Impact factor: 53.106

5.  CCR6 identifies lymphoid tissue inducer cells within cryptopatches.

Authors:  A Lügering; M Ross; M Sieker; J Heidemann; I R Williams; W Domschke; T Kucharzik
Journal:  Clin Exp Immunol       Date:  2010-02-10       Impact factor: 4.330

Review 6.  Humanized mouse models of HIV infection.

Authors:  Paul W Denton; J Víctor García
Journal:  AIDS Rev       Date:  2011 Jul-Sep       Impact factor: 2.500

Review 7.  HIV infection and the gastrointestinal immune system.

Authors:  J M Brenchley; D C Douek
Journal:  Mucosal Immunol       Date:  2008-01       Impact factor: 7.313

8.  Peyer's Patches: The Immune Sensors of the Intestine.

Authors:  Camille Jung; Jean-Pierre Hugot; Frédérick Barreau
Journal:  Int J Inflam       Date:  2010-09-19

9.  Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract.

Authors:  Saurabh Mehandru; Michael A Poles; Klara Tenner-Racz; Amir Horowitz; Arlene Hurley; Christine Hogan; Daniel Boden; Paul Racz; Martin Markowitz
Journal:  J Exp Med       Date:  2004-09-13       Impact factor: 14.307

10.  IL-2 receptor γ-chain molecule is critical for intestinal T-cell reconstitution in humanized mice.

Authors:  P W Denton; T Nochi; A Lim; J F Krisko; F Martinez-Torres; S K Choudhary; A Wahl; R Olesen; W Zou; J P Di Santo; D M Margolis; J V Garcia
Journal:  Mucosal Immunol       Date:  2012-05-09       Impact factor: 7.313

View more
  27 in total

1.  Role of Semen on Vaginal HIV-1 Transmission and Maraviroc Protection.

Authors:  Olivia D Council; Michael D Swanson; Rae Ann Spagnuolo; Angela Wahl; J Victor Garcia
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

Review 2.  Regulation of intestinal IgA responses.

Authors:  Na Xiong; Shaomin Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-03       Impact factor: 9.261

Review 3.  Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases.

Authors:  Iurii Koboziev; Yava Jones-Hall; John F Valentine; Cynthia Reinoso Webb; Kathryn L Furr; Matthew B Grisham
Journal:  Inflamm Bowel Dis       Date:  2015-07       Impact factor: 5.325

Review 4.  The use of BLT humanized mice to investigate the immune reconstitution of the gastrointestinal tract.

Authors:  Angela Wahl; J Victor Garcia
Journal:  J Immunol Methods       Date:  2014-06-18       Impact factor: 2.303

Review 5.  Humanized hemato-lymphoid system mice.

Authors:  Alexandre P A Theocharides; Anthony Rongvaux; Kristin Fritsch; Richard A Flavell; Markus G Manz
Journal:  Haematologica       Date:  2016-01       Impact factor: 9.941

Review 6.  Gut microbiota, metabolites and host immunity.

Authors:  Michelle G Rooks; Wendy S Garrett
Journal:  Nat Rev Immunol       Date:  2016-05-27       Impact factor: 53.106

Review 7.  In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies.

Authors:  Christopher C Nixon; Maud Mavigner; Guido Silvestri; J Victor Garcia
Journal:  J Infect Dis       Date:  2017-03-15       Impact factor: 5.226

Review 8.  BLT humanized mice as a small animal model of HIV infection.

Authors:  Marshall E Karpel; Christian L Boutwell; Todd M Allen
Journal:  Curr Opin Virol       Date:  2015-06-12       Impact factor: 7.090

Review 9.  Humanized mice for HIV and AIDS research.

Authors:  J Victor Garcia
Journal:  Curr Opin Virol       Date:  2016-07-19       Impact factor: 7.090

Review 10.  In vivo platforms for analysis of HIV persistence and eradication.

Authors:  J Victor Garcia
Journal:  J Clin Invest       Date:  2016-02-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.